Curative Biotechnology, Inc. (OTCMKTS:CUBT) Short Interest Up 5,800.0% in August

Curative Biotechnology, Inc. (OTCMKTS:CUBT) saw a large growth in short interest in August. As of August 31st, there was short interest totalling 5,900 shares, a growth of 5,800.0% from the August 15th total of 100 shares. Based on an average daily volume of 26,700 shares, the days-to-cover ratio is currently 0.2 days.

Curative Biotechnology Price Performance

CUBT stock opened at $0.01 on Friday. The company’s 50-day moving average is $0.02 and its 200-day moving average is $0.02. Curative Biotechnology has a 1 year low of $0.00 and a 1 year high of $0.04.

Curative Biotechnology Company Profile

Curative Biotechnology, Inc, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies.